-
Anti-gout drug benzbromarone, must pay attention to these 8 precautions
Time of Update: 2023-02-01
👇Download the Decision Assistant App and check it anytime, anywhere~References: [1] Drug information: benzbromarone tablets, Yichang Dongguang Changjiang Pharmaceutical Co.
👇Download the Decision Assistant App and check it anytime, anywhere~References: [1] Drug information: benzbromarone tablets, Yichang Dongguang Changjiang Pharmaceutical Co.
-
Guangdong Provincial Food and Drug Administration: Sufficient supply of drugs, no need to blindly "stock up on drugs
Time of Update: 2023-01-01
According to the "Guangdong Drug Administration" public account news on December 3, recently, the "new crown medicine order" chart, "new crown drug hoarding list" and so on have gone viral on social platforms, and many citizens and friends have also begun to follow the trend of hoarding medicine, is it really necessary?
-
The success of the CRISPR cancer trial paved the way for personalized treatment
Time of Update: 2022-12-04
"After a series of analyses to confirm their findings, validate their predictions, and design a protein called the T cell receptor, which recognizes tumor mutations, the researchers took blood samples from each participant and inserted the receptor into their T cells using CRISPR genome editing.
-
Get rid of the Red Sea fight API companies turned into CDMO
Time of Update: 2022-11-15
Pharmaceutical active materials (APIs), usually referred to as chemical APIs, are active ingredients in chemical pharmaceutical preparations. China is the world's largest API producer and exporter, w
-
In order to supplement their own strength, large pharmaceutical companies are accelerating "buying, buying and buying
Time of Update: 2022-11-11
On Oct. 18, Eli Lilly said it had agreed to acquire precision genetic drug company Akou in a deal worth up to $610 million.
On Oct. 18, Eli Lilly said it had agreed to acquire precision genetic drug company Akou in a deal worth up to $610 million.
-
Aspheric diffraction multifocal intraocular lenses were approved for marketing
Time of Update: 2022-11-04
The drug regulatory department will strengthen the post-market supervision of the product to protect the safety of patients' devices.
The drug regulatory department will strengthen the post-market supervision of the product to protect the safety of patients' devices.
-
Photodynamic drugs antitumor stem cell and ribosomal inhibition
Time of Update: 2022-10-02
Ribosomes in each mammal copy number is tens of millions, accounting for about 10% of the total copy number of proteins in the cell, 85% of the total RNA, consuming more than 50% of the total ATP of
-
The end of the "Food Safety Longjiang 100-Day Action" in Heilongjiang will create a food safety province
Time of Update: 2022-09-30
Wang Mixia, reporter of this magazine, Wu Yuefu On April 20, the Food Safety Office of the Heilongjiang Provincial Government and the Heilongjiang Provincial Food and Drug Administration organized a
-
Beijing pushes fast food inspection vehicles for mobile random inspection and results in 20 minutes
Time of Update: 2022-09-18
Cong Luoluo, director of the Municipal Food and Drug Administration, said that with rapid testing and results, staff can detect problems in time and keep samples of problems .
-
Leading Japanese pharmaceutical company will launch bioplastic eye drops
Time of Update: 2022-08-23
, Ltd. has been committed to the research and development of new ophthalmic drugs, and is a leading company in the Japanese ophthalmic prescription drug market Since its establishment more than 100 years ago, Santen Pharmaceutical Co.
-
The integration pressure of the pharmaceutical retail market is intensifying
Time of Update: 2022-08-19
[Pharmaceutical Network Market Analysis] Recently, Guangdong Huizhou Medical Insurance Bureau issued an announcement that it intends to terminate the service agreement with 109 medical insurance designated retail pharmacies including Zhengkang Pharmacy in Zhongkai High-tech Zone, Huizhou City .
-
Drug resistance concerns grow, Pfizer refuses to provide new coronavirus oral drug Paxlovid to other organizations for research
Time of Update: 2022-08-15
Ashish Jha of the White House noted that in clinical trials, about 2 percent of patients in the Paxlovid group experienced a rebound in symptoms, compared with about 1.
-
China's first AI research and development candidate drug to reduce hepatitis B surface antigen completes the first patient enrollment
Time of Update: 2022-04-30
(hereinafter referred to as " China-Israel Hyde ") used AI big data to drive the first reduction The clinical trial of the hepatitis B surface antigen drug HDM-8421034 has completed the first patient enrollment in Beijing Tsinghua Chang Gung Memorial Hospital .
-
PNAS: Bats promote virus transmission via salivary gland immunosuppressive toxin
Time of Update: 2022-04-29
A joint team led by Lai Ren, a researcher at the Kunming Institute of Zoology, Chinese Academy of Sciences, found that bats may promote virus residency and transmission through their salivary gland immunosuppressive toxins .
-
AstraZeneca's antibody cocktail Evusheld gets UK MHRA authorisation for COVID-19 pre-exposure prophylaxis
Time of Update: 2022-04-19
The primary data from the ongoing Phase III trial (PROVENT study), which has met its primary endpoint, showed a statistically in the risk of symptomatic COVID-19 in the Evusheld group compared to placebo .
